Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors TAIPEI, May 6, 2025 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced… CISION PRNewswireMay 6, 2025
NYSE Content Advisory: Pre-Market update + Federal Reserve begins two-day policy meeting NEW YORK, May 6, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireMay 6, 2025
GameChange Solar strengthens regional position across MENA and Central Asia with a 3.6 GW portfolio DUBAI, UAE, May 6, 2025 /PRNewswire/ — GameChange Solar, a leading global… CISION PRNewswireMay 6, 2025
Press ReleaseEricsson, Nokia, ANDREW, and Huawei Take Top Spots in ABI Research's DAS/DRS Vendors Competitive Ranking LONDON, May 6, 2025 /PRNewswire/ — Driven by the growing demand for… CISION PRNewswireMay 6, 2025
Press ReleaseSpreeAI Is Redefining Retail With Virtual AI-Powered Try-Ons Curated by the Top in Tech and Fashion SpreeAI celebrates a $1.5 billion valuation as it prepares for groundbreaking partnerships… CISION PRNewswireMay 6, 2025
BusinessPress ReleaseFIC Global Expands Optical Transceiver Business to Enable Innovation at the Speed of Light TAIPEI, May 6, 2025 /PRNewswire/ — FIC Global Inc. (TWSE: 3701; FICG),… CISION PRNewswireMay 6, 2025
Press ReleaseSK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats Company aims to develop a bird flu vaccine with rapid mass production… CISION PRNewswireMay 6, 2025
Press ReleaseNiall Prendiville Joins CSafe as Chief Product Officer to Drive Continued Growth in Innovation Across the Product Portfolio Prendiville brings over 25 years of expertise in product, engineering, automation and… CISION PRNewswireMay 6, 2025
